Virtual Travel Into Nature for Individuals With Lived Experience of Severe Mental Disorders
Inpatient VR
Bringing Nature Into a Psychiatric Ward: Virtual Travels for Inpatient Care in People With Lived Experience of a Severe Mental Disorder
1 other identifier
interventional
98
1 country
1
Brief Summary
The goal of the (observational or clinical) trial is to assess the use of the virtual application Toujours Dimanche for individuals hospitalized in a psychiatric care unit. The main questions it aims to answer are:
- Is it feasible and acceptable for individuals currently hospitalized to use virtual reality during their stay?
- What are the effects on mental health of the virtual reality application in individuals hospitalized in psychiatric care?
- What are the barriers and facilitators of using the virtual reality application in a psychiatric ward from the perspective of service users and health care providers? Researchers will compare virtual reality users to control group (treatment as usual only) to see if the use of the application affects social and emotional well-being in the context of hospitalisation in psychiatry. In the first phase, participants will: \- Be invited to participate in focus groups to assess their interest in the application. In the second phase, participants will:
- Complete baseline questionnaires on their connection to nature and social and emotional well-being.
- Use the virtual reality application over a 15 day period alongside treatment as usual.
- Complete post-intervention questionnaires and a survey on their use and opinions of the application. Healthcare provider feedback phase \- Healthcare providers working on the unit will be invited to share their perception of the impact of implementing the virtual application on the unit through surveys which will be sent by email.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 13, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 27, 2024
CompletedFirst Submitted
Initial submission to the registry
March 18, 2025
CompletedFirst Posted
Study publicly available on registry
March 25, 2025
CompletedApril 3, 2025
March 1, 2025
5 months
March 18, 2025
March 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Perceived Stress Scale
The Perceived Stress Scale (PSS), a 10-item self-report questionnaire assessing subjective stress using a Likert scale from 1 (never) to 5 (very often) (Cohen \& Williamson, 1988). For the current study, the questionnaire will be modified to adjust the timeframe for the assessment of perceived stress from one moth to two weeks.
Change from baseline (15 days post)
Kessler Psychological Distress Scale
The Kessler Psychological Distress Scale (K10) (Kessler et al., 2002) is a 10-item self-report questionnaire assessing distress through questions about anxiety and depression. The 10 items are rated on a Likert scale ranging from 1 (None of the time) to 5 (All the time).
Change from baseline (15 days post)
Beck Anxiety Scale
The Beck Anxiety Scale (BAI; (Beck et al., 1988)) is a self-report questionnaire that includes 21 items rated on a Likert scale of 0 (not at all) to 3 (Severely).
Change from baseline (15 days post)
The connectedness to nature scale
The connectedness to nature scale (CNS) (Mayer \& Frantz, 2004) is a 14 self-report item questionnaire that assesses individuals' trait levels of feeling emotionally connected to the natural world.
Change from baseline (15 days post)
PHQ-9
Depressive symptoms will be assessed using the PHQ-9. This 9-item self-report questionnaire assesses depressive symptoms in the last two weeks, rated on a Likert scale ranging from 0 (not at all) to 3 (nearly every day)
Change from baseline (15 days post)
Warwick-Edinburgh Mental Well-being Scale
Wellbeing will be assessed with the Warwick-Edinburgh Mental Well-being Scale (WEMWBS), a 14-item self-report questionnaire using a Likert scale from 1 (never) to 5 (all the time).
Change from baseline (15 days post)
De Jong Gierveld Loneliness Scale - short version
Social isolation will be assessed with the De Jong Gierveld Loneliness Scale - short version (DJGLS). This 6-item self-report questionnaire assess overall, emotional, and social loneliness using a Likert scale ranging from 0 (not lonely) to 11 (extremely lonely).
Change from baseline (15 days post)
Study Arms (2)
Toujours Dimanche users
EXPERIMENTALParticipants who will use the virtual reality application Toujours Dimanche in the context of their hospitalization in psychiatric care. Participants will receive treatment as usual and will be able to use the application at their leisure for a period of 15 days.
Control group
NO INTERVENTIONParticipants will not use the virtual reality application Toujours Dimanche. Will receive treatment as usual.
Interventions
The use of the virtual travel-into-nature application which features real natural environments from the Eastern Canada area.
Eligibility Criteria
You may qualify if:
- Being 18 years old or older
- Being hospitalized in a psychiatric unit at the time of the study
- Being relatively clinically stable, according to the treating psychiatrist
- Being free of uncorrected visual impairments
- Being able to speak or read French or English
You may not qualify if:
- Current photosensitive epilepsy or a history of seizures
- Previous history of severe motion sickness or cyber-sickness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Douglas Mental Health University Institute
Montreal, Quebec, H4H 1R3, Canada
Related Publications (3)
Tennant R, Hiller L, Fishwick R, Platt S, Joseph S, Weich S, Parkinson J, Secker J, Stewart-Brown S. The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007 Nov 27;5:63. doi: 10.1186/1477-7525-5-63.
PMID: 18042300BACKGROUNDGierveld JDJ, Tilburg TV. A 6-Item Scale for Overall, Emotional, and Social Loneliness: Confirmatory Tests on Survey Data. Research on Aging 2006;28(5):582-598.
BACKGROUNDKroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.
PMID: 11556941BACKGROUND
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Élisabeth Thibaudeau, Ph.D.
Laval University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Scientific Director
Study Record Dates
First Submitted
March 18, 2025
First Posted
March 25, 2025
Study Start
March 11, 2024
Primary Completion
August 13, 2024
Study Completion
August 27, 2024
Last Updated
April 3, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
The data from this project are collected with people hospitalized in only one specific unit at the Douglas hospital and sharing their individual data might comprise their confidentiality.